Precigen’s leadership team outlined rapid early commercialization progress for its recently approved therapy PAPZIMEOS during a Wednesday, March 25, 2026, update call covering fourth-quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results